Predictive factors for the efficacy of switch to oral hypoglycemic agents in Japanese type 2 diabetic patients with intensive insulin therapy temporarily introduced-Reference-Cited by-同舟云学术

Predictive factors for the efficacy of switch to oral hypoglycemic agents in Japanese type 2 diabetic patients with intensive insulin therapy temporarily introduced

Published:2014 Issue:9 Volume:61 Page:911-919
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Yamamoto Yuichi¹,Takahara Mitsuyoshi¹,Yasuda Tetsuyuki¹,Katakami Naoto¹²,Matsuoka Taka-aki¹,Kaneto Hideaki¹,Shimomura Iichiro¹

Affiliation:

1. Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan

2. Department of Metabolism and Atherosclerosis, Osaka University Graduate School of Medicine, Suita 565-0871, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/61/9/61_EJ14-0011/_pdf

Reference41 articles.

1. 1. Niswender K (2009) Early and aggressive initiation of insulin therapy for type 2 diabetes: What Is the evidence? Clin Diabetes 27: 60-68.

2. 2. U.K. Prospective Diabetes Study Group (1995) U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 44: 1249-1258.

3. 3. Defronzo RA (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773-795.

4. 4. Festa A, Williams K, D’Agostino R Jr, Wagenknecht LE, Haffner SM (2006) The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 55: 1114-1120.

5. 5. Lee SW, Lee S, Kim SH, Kim TH, Kang BS, et al. (2011) Parameters measuring beta-cell function are only valuable in diabetic subjects with low body mass index, high blood glucose level, or long-standing diabetes. Yonsei Med J 52(6): 939-947.